Karen L. Burton - 11 Nov 2026 Form 4 Insider Report for STERIS plc (STE)

Reporting relationship: Sr. Vice Pres., CFO
Issuer ticker: STE
Reported as of: 11 Nov 2026
Net transaction value: -$1,503,046
SEC form: 4
Accepted by SEC: 12 Nov 2026, 16:32:18 UTC
Prior SEC filing: 05 Oct 2026
Source filing: View source filing
Reporting owner signature: /s/ John P. Ubbing, Authorized Representative under Power of Attorney

Filing notes and source

Key filing fact

Karen L. Burton filed Form 4 for STERIS plc (STE) on 12 Nov 2026.

Key facts

This page summarizes Karen L. Burton's Form 4 filing for STERIS plc (STE).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 12 Nov 2026, 16:32.

Change

Previous filing in this sequence was filed on 05 Oct 2026.
Current net transaction value: -$1,503,046.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001697095 Primary reporting owner

Burton Karen L

Relationship: Sr. Vice Pres., CFO
Address: 70 SIR JOHN ROGERSON'S QUAY, DUBLIN 2, IRELAND
Signature: /s/ John P. Ubbing, Authorized Representative under Power of Attorney
Signature date: 12 Nov 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

STE transaction

Ordinary Shares

Options Exercise

Transaction value
Shares: +5,880
Change %: +45%
Price: $147.05^*
Shares after: 18,836
Date: 11 Nov 2026
Ownership: Direct

STE transaction

Ordinary Shares

Sale

Transaction value: -$1,503,046
Shares: -5,880
Change %: -31%
Price: $255.62
Shares after: 12,956
Date: 11 Nov 2026
Ownership: Direct
Footnotes: F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

STE transaction Derivative

Employee Stock Option (right to buy)

Options Exercise

Transaction value
Shares: -5,880
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 11 Nov 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 5,880
Exercise price: $147.05
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Price reflects a weighted average sale price for multiple transactions ranging from $255.22 to $256.18 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Footnote F2

As of November 12, 2026, 8,499 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 1,775 on June 2, 2027; 651 on June 3, 2027; 306 on June 4, 2027; 783 on October 1, 2027; 1,775 on June 2, 2028; 651 on June 5, 2028; 783 on October 1, 2028 and 1,775 on June 4, 2029.

Footnote F3

This option to purchase 5,880 STERIS plc ordinary shares, which is fully vested, was received in connection with the redomiciliation of STERIS plc to Ireland in March 2019 in exchange for an option to purchase 5,880 ordinary shares for $147.05 per share in STERIS plc prior to the redomiciliation ("Old STERIS"), subject to the same terms and conditions as the original Old STERIS stock option.